THE EFFICIENCY OF USING THE MEDICATION COMBING 150 MG OF ISONIAZID , 375 MG OF PYRAZINA MIDE , 150 MG OF RI FAMPICIN IN THE TREATMEN T OF RESPIRATOR Y TUBERCULOSIS IN CHILDREN
The main problem for treatment of children with various manifestations of tuberculosis is the lack of pediatric dosages of anti-tuberculosis drugs. Considering the current problems when providing treatment it is important to use combined medications with fixed pediatric dosages, which would signific...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
New Terra Publishing House
2017-08-01
|
| Series: | Туберкулез и болезни лёгких |
| Subjects: | |
| Online Access: | https://www.tibl-journal.com/jour/article/view/1023 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850223498792796160 |
|---|---|
| author | Yu. E. Ovchinnikovа A. A. Stаrshinovа I. F. Dovgаlyuk |
| author_facet | Yu. E. Ovchinnikovа A. A. Stаrshinovа I. F. Dovgаlyuk |
| author_sort | Yu. E. Ovchinnikovа |
| collection | DOAJ |
| description | The main problem for treatment of children with various manifestations of tuberculosis is the lack of pediatric dosages of anti-tuberculosis drugs. Considering the current problems when providing treatment it is important to use combined medications with fixed pediatric dosages, which would significantly help to simplify the administration of medications and to relieve the psychological, emotional and physical load when taking a significant number of drugs.Goal of the study: to define the efficiency of using fixed doses of the medication combing 150 mg of isoniazid, 375 mg of pyrazinamide, 150 mg of rifampicin. Clinical, X-ray and laboratory rates were assessed during treatment of 73 children suffering from respiratory tuberculosis, of them 34 children were treated by the medication combing 150 mg of isoniazid, 375 mg of pyrazinamide, 150 mg of rifampicin plus ethambutol, and the other children were treated by the standard chemotherapy. The opportunity of effective use of the medication combining 150 mg of isoniazid, 375 mg of pyrazinamide, 150 mg of rifampicin in children was confirmed by positive results by the completion of the intensive phase of treatment as well as the continuation phase and minimization of adverse reactions during treatment. The combination of active components of the medication and doses is convenient for use, allow conducting directly observed treatment and enhancing the efficiency of chemotherapy. |
| format | Article |
| id | doaj-art-32ab663a0c0d4d77b31424db6de6fb75 |
| institution | OA Journals |
| issn | 2075-1230 2542-1506 |
| language | Russian |
| publishDate | 2017-08-01 |
| publisher | New Terra Publishing House |
| record_format | Article |
| series | Туберкулез и болезни лёгких |
| spelling | doaj-art-32ab663a0c0d4d77b31424db6de6fb752025-08-20T02:05:56ZrusNew Terra Publishing HouseТуберкулез и болезни лёгких2075-12302542-15062017-08-01957485310.21292/2075-1230-2017-95-7-48-531023THE EFFICIENCY OF USING THE MEDICATION COMBING 150 MG OF ISONIAZID , 375 MG OF PYRAZINA MIDE , 150 MG OF RI FAMPICIN IN THE TREATMEN T OF RESPIRATOR Y TUBERCULOSIS IN CHILDRENYu. E. Ovchinnikovа0A. A. Stаrshinovа1I. F. Dovgаlyuk2St. Petersburg Research Institute of PhthisiopulmonologySt. Petersburg Research Institute of PhthisiopulmonologySt. Petersburg Research Institute of PhthisiopulmonologyThe main problem for treatment of children with various manifestations of tuberculosis is the lack of pediatric dosages of anti-tuberculosis drugs. Considering the current problems when providing treatment it is important to use combined medications with fixed pediatric dosages, which would significantly help to simplify the administration of medications and to relieve the psychological, emotional and physical load when taking a significant number of drugs.Goal of the study: to define the efficiency of using fixed doses of the medication combing 150 mg of isoniazid, 375 mg of pyrazinamide, 150 mg of rifampicin. Clinical, X-ray and laboratory rates were assessed during treatment of 73 children suffering from respiratory tuberculosis, of them 34 children were treated by the medication combing 150 mg of isoniazid, 375 mg of pyrazinamide, 150 mg of rifampicin plus ethambutol, and the other children were treated by the standard chemotherapy. The opportunity of effective use of the medication combining 150 mg of isoniazid, 375 mg of pyrazinamide, 150 mg of rifampicin in children was confirmed by positive results by the completion of the intensive phase of treatment as well as the continuation phase and minimization of adverse reactions during treatment. The combination of active components of the medication and doses is convenient for use, allow conducting directly observed treatment and enhancing the efficiency of chemotherapy.https://www.tibl-journal.com/jour/article/view/1023respiratory tuberculosischildrenmedication with combined fixed dosesadverse reactionschemotherapy efficiency |
| spellingShingle | Yu. E. Ovchinnikovа A. A. Stаrshinovа I. F. Dovgаlyuk THE EFFICIENCY OF USING THE MEDICATION COMBING 150 MG OF ISONIAZID , 375 MG OF PYRAZINA MIDE , 150 MG OF RI FAMPICIN IN THE TREATMEN T OF RESPIRATOR Y TUBERCULOSIS IN CHILDREN Туберкулез и болезни лёгких respiratory tuberculosis children medication with combined fixed doses adverse reactions chemotherapy efficiency |
| title | THE EFFICIENCY OF USING THE MEDICATION COMBING 150 MG OF ISONIAZID , 375 MG OF PYRAZINA MIDE , 150 MG OF RI FAMPICIN IN THE TREATMEN T OF RESPIRATOR Y TUBERCULOSIS IN CHILDREN |
| title_full | THE EFFICIENCY OF USING THE MEDICATION COMBING 150 MG OF ISONIAZID , 375 MG OF PYRAZINA MIDE , 150 MG OF RI FAMPICIN IN THE TREATMEN T OF RESPIRATOR Y TUBERCULOSIS IN CHILDREN |
| title_fullStr | THE EFFICIENCY OF USING THE MEDICATION COMBING 150 MG OF ISONIAZID , 375 MG OF PYRAZINA MIDE , 150 MG OF RI FAMPICIN IN THE TREATMEN T OF RESPIRATOR Y TUBERCULOSIS IN CHILDREN |
| title_full_unstemmed | THE EFFICIENCY OF USING THE MEDICATION COMBING 150 MG OF ISONIAZID , 375 MG OF PYRAZINA MIDE , 150 MG OF RI FAMPICIN IN THE TREATMEN T OF RESPIRATOR Y TUBERCULOSIS IN CHILDREN |
| title_short | THE EFFICIENCY OF USING THE MEDICATION COMBING 150 MG OF ISONIAZID , 375 MG OF PYRAZINA MIDE , 150 MG OF RI FAMPICIN IN THE TREATMEN T OF RESPIRATOR Y TUBERCULOSIS IN CHILDREN |
| title_sort | efficiency of using the medication combing 150 mg of isoniazid 375 mg of pyrazina mide 150 mg of ri fampicin in the treatmen t of respirator y tuberculosis in children |
| topic | respiratory tuberculosis children medication with combined fixed doses adverse reactions chemotherapy efficiency |
| url | https://www.tibl-journal.com/jour/article/view/1023 |
| work_keys_str_mv | AT yueovchinnikova theefficiencyofusingthemedicationcombing150mgofisoniazid375mgofpyrazinamide150mgofrifampicininthetreatmentofrespiratorytuberculosisinchildren AT aastarshinova theefficiencyofusingthemedicationcombing150mgofisoniazid375mgofpyrazinamide150mgofrifampicininthetreatmentofrespiratorytuberculosisinchildren AT ifdovgalyuk theefficiencyofusingthemedicationcombing150mgofisoniazid375mgofpyrazinamide150mgofrifampicininthetreatmentofrespiratorytuberculosisinchildren AT yueovchinnikova efficiencyofusingthemedicationcombing150mgofisoniazid375mgofpyrazinamide150mgofrifampicininthetreatmentofrespiratorytuberculosisinchildren AT aastarshinova efficiencyofusingthemedicationcombing150mgofisoniazid375mgofpyrazinamide150mgofrifampicininthetreatmentofrespiratorytuberculosisinchildren AT ifdovgalyuk efficiencyofusingthemedicationcombing150mgofisoniazid375mgofpyrazinamide150mgofrifampicininthetreatmentofrespiratorytuberculosisinchildren |